XTL Biopharmaceuticals Ltd. (XTLB)
XTLB Stock Price Chart
Explore XTL Biopharmaceuticals Ltd. interactive price chart. Choose custom timeframes to analyze XTLB price movements and trends.
XTLB Company Profile
Discover essential business fundamentals and corporate details for XTL Biopharmaceuticals Ltd. (XTLB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Sept 2005
Employees
10.00
Website
https://www.xtlbio.comCEO
Noam Band
Description
XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to identifying and advancing novel drug therapies for autoimmune conditions. Its primary investigational compound, hCDR1, is poised to enter Phase II trials, specifically targeting systemic lupus erythematosus and Sjogren's syndrome. The company holds a crucial licensing agreement with Yeda Research and Development Company Limited, which grants rights for the research, development, and eventual commercialization of hCDR1 across multiple therapeutic indications. Originally established in 1993 as Xenograft Technologies Ltd., the company rebranded to XTL Biopharmaceuticals Ltd. in July 1995. It operates from its headquarters in Ramat Gan, Israel.
XTLB Financial Timeline
Browse a chronological timeline of XTL Biopharmaceuticals Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 29 Apr 2026
Stock split effective on 25 Mar 2026
Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 29 Dec 2025
EPS came in at -$0.36 .
Stock split effective on 24 Dec 2025
Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Jun 2025
EPS came in at $0.10 .
Earnings released on 30 Jun 2025
EPS came in at $0.10 .
Earnings released on 1 Jan 2025
EPS came in at -$0.04 , while revenue for the quarter reached $289.00k .
Earnings released on 30 Dec 2024
EPS came in at -$0.13 , while revenue for the quarter reached $162.00k .
Earnings released on 26 Sept 2024
EPS came in at -$0.07 .
Earnings released on 13 May 2024
EPS came in at $0.10 .
Earnings released on 27 Mar 2024
EPS came in at -$0.14 .
Earnings released on 15 Nov 2023
EPS came in at -$0.04 .
Earnings released on 10 Aug 2023
EPS came in at -$0.07 .
Earnings released on 16 May 2023
EPS came in at -$0.17 .
Earnings released on 22 Mar 2023
EPS came in at -$0.14 .
Earnings released on 29 Nov 2022
EPS came in at -$0.15 .
Earnings released on 24 Aug 2022
EPS came in at -$0.10 .
Earnings released on 1 Jun 2022
EPS came in at $1.49 .
Earnings released on 30 Mar 2022
EPS came in at $0.40 .
Earnings released on 24 Nov 2021
EPS came in at -$1.52 .
Earnings released on 24 Aug 2021
EPS came in at -$0.22 .
XTLB Stock Performance
Access detailed XTLB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
